Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

pembrolizumab 604Carboplatin 372Paclitaxel 282Cisplatin 267Gemcitabine 253Pemetrexed 193Bevacizumab 190Docetaxel 188Nivolumab 182Injections 167Cyclophosphamide 147atezolizumab 138Capecitabine 134Fluorouracil 133Oxaliplatin 132Dexamethasone 128Fulvestrant 113durvalumab 112130-nm albumin-bound paclitaxel 110fludarabine 101Cetuximab 100Leucovorin 97Rituximab 94venetoclax 90Lenalidomide 83enzalutamide 77Prednisone 77Azacitidine 74Irinotecan 73Ipilimumab 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × CD3 Complex × 1 year × Clear all
NCT07408258 2026-06-04

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

OncoC4, Inc.

Phase 1 Not yet recruiting
20 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡